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Appraisal Clinical Practice Guidelines
Juvenile idiopathic arthritis
Clinical guideline for the diagnosis and management of juvenile idiopathic arthritis
Latest update: August 2009. Date of next update: 2014. 
Patient group: Patients aged under 16 years presenting 
with arthritic symptoms and those diagnosed with 
Juvenile idiopathic arthritis (JIA). Intended audience: 
Health professionals (general practitioners and allied 
health including physiotherapy) in the primary health care 
setting. Additional versions: Nil. Expert working group: 
Two working groups were involved: the Royal Australian 
College of General Practitioners (RACGP) Juvenile 
Idiopathic Arthritis Working Group consisted of 8 health 
care professionals (representing medicine, nursing, public 
health, and physiotherapy) and a consumer representative. 
The Australian Paediatric Rheumatology Working Group 
consisted of 7 medical fellows. Funded by: RACGP 
and the Australian Department of Health and Ageing. 
Consultation with: Draft versions of the guidelines were 
available on the RACGP website for public consultation, 
and over 200 stakeholder groups were targeted speciﬁcally. 
Approved by: National Health and Medical Research 
Council of Australia, RACGP. Location: http://www.racgp.
org.au/guidelines/juvenileidiopathicarthritis
Description: This is a 43-page document that presents 
recommendations to assist with the early diagnosis and 
multidisciplinary management of JIA in the primary care 
setting. The guideline focuses on evidence underpinning 
four main areas: the diagnosis of JIA, treatment and 
management of JIA in the early stage, during acute episodes, 
and the long term management of JIA. It covers issues such 
as early and accurate diagnosis, care and referral pathways, 
use of medications, non-pharmacological management 
including evidence for land and water exercise, patient 
self-management education, and psychosocial support 
requirements. Two detailed algorithms are presented on 
pages 8 and 9, covering the diagnosis and early management 
of JIA, and the management of JIA. A summary of the 
21 recommendations is presented on pages 10–11, with 
more detailed explanation of the recommendation level 
and speciﬁc evidence contained in pages 12–24. Three 
pages of resources are provided on pages 35–37 including 
publications, electronic sources (websites), and a history and 
clinical examination checklist to assist with examination 
and differential diagnosis. 
Sandra Brauer




Latest update: May 2010. Date of next update: 2014. 
Patient group: Individuals with chronic obstructive 
pulmonary disease (COPD). Intended audience: Health 
professionals who manage patients with COPD. Additional 
versions: This is the ﬁrst update to the guidelines. The 
original guidelines were published in the Medical Journal 
of Australia in 2003. (http://www.mja.com.au/public/
issues/178 06 170303/tho10508 all.html). Expert working 
group: The guidelines were developed by the Australian 
Lung Foundation and the Thoracic Society of Australia 
and New ealand. The guidelines evaluation committee 
consisted of 8 Australian health professionals representing 
medicine, public health, and physiotherapy. A larger group 
of 27 experts from Australia and New ealand including 
physiotherapists also contributed. Funded by: Australian 
Lung Foundation. Consultation with: Draft versions of 
the guidelines were available on the RACGP website for 
public consultation and over 200 stakeholder groups were 
speciﬁcally targeted. Approved by: The Royal Australian 
College of Physicians, The Royal College of Nursing 
Australia, the Australian Physiotherapy Association, 
Australian Asthma and Respiratory Educators Association, 
and the Asthma Foundation. Location: The website (http://
www.copdx.org.au/home) contains the guidelines spread 
over pages on the site, as well as a .pdf version.
Description: The .pdf version is a 71-page document that 
presents recommendations and the underlying evidence 
to assist with the diagnosis and management of patients 
with COPD. The key recommendations are summarised 
on page 10 in the COPD-  plan: Conﬁrm diagnosis, 
Optimise function, Prevent deterioration, Develop a self-
management plan, and manage eXacerbations. Information 
is presented on the aetiology and natural history of COPD, 
the role of history, physical examination, and spirometry 
in diagnosis, methods to assess severity, and indicators 
for referral to specialist respiratory care. The evidence 
for the efﬁcacy of medication and non-pharmacological 
approaches to optimise function is discussed, including 
exercise, education and self management, pulmonary 
rehabilitation, chest physiotherapy, psychosocial support, 
and nutrition. Likely co-morbidities and their management 
are presented, and surgical options and palliative care 
are discussed. Evidence and approaches for the reduction 
of risk factors such as smoking cessation, medication, 
vaccination, and oxygen therapy are presented. The section 
on self management promotes a multidisciplinary team 
approach. Evidence underpinning the management of 
acute exacerbations is presented. This includes guidelines 
to conﬁrm the exacerbation and categorise its severity, 
pharmacological and non-pharmacological interventions, 
indicators for hospitalisation or ventilation, and discharge 
planning. Appendices provide information on inhaler 
devices, and long-term oxygen therapy.
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